HOLX · US market

HOLOGIC INC

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$16.97bnFinancials dated 27 December 2025Price dated 6 April 2026

Core valuation

Trailing P/E31.20×

Latest-quarter run-rate P/E23.69×

Trailing P/S4.11×

Latest-quarter run-rate P/S4.05×

Calculation inputs

Trailing earnings: US$543.80m
Latest-quarter run-rate earnings: US$716.40m
Latest fiscal-year earnings: US$565.70m
Trailing revenue: US$4.13bn
Latest-quarter run-rate revenue: US$4.19bn
Latest fiscal-year revenue: US$4.10bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

IHI · iShares U.S. Medical Devices ETF0.00% weight · Holdings dated 19 August 2026
LCTU · iShares U.S. Carbon Transition Readiness Aware Active ETF0.00% weight · Holdings dated 21 August 2026
ESMV · iShares ESG Optimized MSCI USA Min Vol Factor ETF0.00% weight · Holdings dated 21 August 2026
ACWV · iShares MSCI Global Min Vol Factor ETF0.00% weight · Holdings dated 21 August 2026
IMCV · iShares Morningstar Mid-Cap Value ETF0.00% weight · Holdings dated 19 August 2026
IYH · iShares U.S. Healthcare ETF0.00% weight · Holdings dated 19 August 2026
EUSA · iShares MSCI USA Equal Weighted ETF0.00% weight · Holdings dated 19 August 2026
GLOF · iShares Global Equity Factor ETF0.00% weight · Holdings dated 21 August 2026
IWS · iShares Russell Mid-Cap Value ETF0.00% weight · Holdings dated 19 August 2026
IXJ · iShares Global Healthcare ETF0.00% weight · Holdings dated 21 August 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 27 December 2025. Informational research, not investment advice.